Population Health Sciences

You are here

Publications

Found 311 results

Filters: First Letter Of Last Name is M [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E

Ghomrawi HMK, Alexiades M, Pavlov H, Nam D, Endo Y, Mandl LA, Mushlin AI. 2014. Evaluation of two appropriateness criteria for total knee replacement.. Arthritis Care Res (Hoboken). 66(11):1749-53.

Yan P, Melman T, Yan S, Otgonsuren M, Grinspan Z. 2017. Evaluation of a novel median power spectrogram for seizure detection by non-neurophysiologists.. Seizure. 50:109-117.

Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR. 2019. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.

Mullangi S, Kaushal R, Ibrahim SA. 2019. Equity in the Age of Health Care Information Technology and Innovation: Addressing the Digital Divide.. Med Care. 57 Suppl 6 Suppl 2:S106-S107.

Honarvar H, Agarwal C, Somani S, Vaid A, Lampert J, Wanyan T, Reddy VY, Nadkarni GN, Miotto R, Zitnik M et al.. 2022. Enhancing convolutional neural network predictions of electrocardiograms with left ventricular dysfunction using a novel sub-waveform representation.. Cardiovasc Digit Health J. 3(5):220-231.

Sharma SK, Momose K, Sedrakyan A, Sonoda T, Sharaiha RZ. 2019. Endoscopic stabilization device evaluation using IDEAL framework: A quality improvement study.. Int J Surg. 67:18-23.

Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al.. 2020. Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.

Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al.. 2020. Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.

Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al.. 2020. Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.

Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al.. 2020. Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.

Murphy S, Friesner DL, Rosenman R, Waslo CS, Au J, Tanne E. 2019. Emergency department utilization among individuals with idiopathic intracranial hypertension.. Int J Health Care Qual Assur. 32(1):152-163.

Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al.. 2020. Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.

Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al.. 2020. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)

Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al.. 2020. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)

Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al.. 2020. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)

Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al.. 2020. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)

Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al.. 2019. Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.

Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al.. 2019. Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.

Navathe AS, Volpp KG, Caldarella KL, Bond A, Troxel AB, Zhu J, Matloubieh S, Lyon Z, Mishra A, Sacks L et al.. 2019. Effect of Financial Bonus Size, Loss Aversion, and Increased Social Pressure on Physician Pay-for-Performance: A Randomized Clinical Trial and Cohort Study.. JAMA Netw Open. 2(2):e187950.

Flory JH, Mushlin AI. 2020. Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes.. Diabetes Care.

Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM. 2020. Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.

Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM. 2020. Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.

Jalali A, Ryan DA, McCollister KE, Marsch LA, Schackman BR, Murphy SM. 2020. Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future.. J Subst Abuse Treat. 112S:18-27.

Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al.. 2017. Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.

Ancker JS, Mauer E, Kalish RB, Vest JR, J Gossey T. 2019. Early Adopters of Patient-Generated Health Data Upload in an Electronic Patient Portal.. Appl Clin Inform. 10(2):254-260.